The Role of Economic Evaluation in Vaccine Decision Making: Focus on Meningococcal Group C Conjugate Vaccine

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.9, 2005-01, pp. : 855-874

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Meningococcal group C conjugate vaccine immunogenic in infants

Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Meningococcal vaccine group C conjugate: Status epilepticus in a child: case report

Reactions Weekly, Vol. 1, Iss. 1399, 2012-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Hepatitis B vaccine/meningococcal vaccine group C conjugate: Eosinophilic myocarditis: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1219, 2008-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

Meningococcal group C conjugate vaccine `very safe' says UK DoH

Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

DTaP vaccine/hepatitis A vaccine/meningococcal vaccine conjugate: Myopericarditis (first report with hepatitis A vaccine and meningococcal vaccine conjugate): case report

Reactions Weekly, Vol. 1, Iss. 1157, 2007-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite